Zydus Lifesciences Gets USFDA Nod for Generic Parkinson's Drug
August 28, 2024 16:25
Zydus Lifesciences has received USFDA approval for Amantadine extended-release capsules, a generic medication for Parkinson's disease, providing 180 days of exclusivity.